Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nitric oxide (NO) is a colorless gas and a principal oxide of nitrogen. It is a free radical that acts as an essential signaling molecule in mammals, playing significant roles in vasodilation, neurotransmission, and immune response. It is produced from L-arginine by nitric oxide synthase (NOS) enzymes. Its activity ends upon reaction with substrates such as oxygen or superoxide radicals.
Nitric oxide acts as a vasodilator by relaxing smooth muscle cells in blood vessels, increasing blood flow and decreasing blood pressure. It also modifies protein function via S-nitrosylation or interaction with transition metal centers within proteins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitric oxide (NO).